Despite the progress made to improve therapeutic outcomes for acute myeloid leukemia (AML). many unmet clinical needs remain to be resolved. Unlike existing anti-AML strategies. here we developed a biomimetic nanocomposite to efficiently eliminate the leukemia cells in the bone marrow and prevent the homing of AML. https://www.animationbengal.com/?w=top-sale-napoleon-perdis-the-one-concealer-on-sale-great-pick